JPRN-jRCT1080223318未知4 期
A Phase 4 Study of Dulaglutide When Added to Insulin Treatment in Patients With Type 2 Diabetes
适应症
试验速览
- 阶段
- 4 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants who have had a diagnosis of type 2 diabetes mellitus.
- •Participants who have been treated with insulin therapy (basal insulin, premixed insulin, or basal/mealtime insulin regimen) with or without 1 or 2 oral antidiabetics (OADs) at stable dose for at least 3 months before screening.
- •Participants who have an HbA1c value (greater than or equal 7.0%) and (less than or equal 10.5%) at screening if the participant is washing out OADs (dipeptidyl peptidase-4 [DPP-4] inhibitors, sulfonylurea [SU], or glinides) or (greater than or equal 7.5%) and (less than or equal 10.5%) at screening if the participant is not washing out OADs.
- •Participants who have stable weight (+-5%) (greater than or equal 3 months) prior to screening.
- •Participants who have a body mass index (BMI) of 18.5 to 35.0 kilograms per meter squared (kilogram per square meter).
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40
未知
不适用
Examination of additive effects of dulaglutide and empagliflozin to type 2 diabetic patients with poor glycemic control despite insulin administration.type 2 diabetes mellitusJPRN-UMIN000024703Social medical corporations Aijinkai Chibune hospital50
已完成
不适用
Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000042812Edogawa Hospital101
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30